Ltd Medimmune serves as Executive at Aevi Genomic Medicine, Inc., where they oversee executive responsibilities. Since joining the company, Ltd Medimmune has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 19, 2019 involved purchasing 12,946,900 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 19, 2019 | GNMX | $0 | Purchase | 12,946,900 | $N/A | Discretionary |
Ltd Medimmune currently holds 12,946,900 shares of Aevi Genomic Medicine, Inc. (GNMX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ltd Medimmune has been a net neutral trader of GNMX stock. They have purchased $0 and sold $0 worth of shares.
Ltd Medimmune's most recent insider trade was on Dec 19, 2019, when they purchased 12,946,900 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted